H1N1 Infection Pipeline Review H2 2013:Industry Analysis Report

227 views
161 views

Published on

H1N1 Infection Pipeline Review H2 2013:Industry Analysis Report @ http://www.researchmoz.us/h1n1-infection-pipeline-review-h2-2013-report.html

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
227
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

H1N1 Infection Pipeline Review H2 2013:Industry Analysis Report

  1. 1. H1N1 Infection - Pipeline Review, H2 2013 H1N1 Infection - Pipeline Review, H2 2013 Summary Global Markets Directs, 'H1N1 Infection - Pipeline Review, H2 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for H1N1 Infection, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for H1N1 Infection. H1N1 Infection - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario for H1N1 Infection. - A review of the H1N1 Infection products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the H1N1 Infection pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for H1N1 Infection. - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players of the most promising pipeline. - Devise corrective measures for pipeline projects by understanding H1N1 Infection pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline. H1N1 Infection - Pipeline Review, H2 2013
  2. 2. Table Of Contents table Of Contents 2 list Of Tables 5 list Of Figures 6 introduction 7 global Markets Direct Report Coverage 7 h1n1 Infection Overview 8 therapeutics Development 9 an Overview Of Pipeline Products For H1n1 Infection 9 h1n1 Infection Therapeutics Under Development By Companies 11 h1n1 Infection Therapeutics Under Investigation By Universities/institutes 15 late Stage Products 16 comparative Analysis 16 mid Clinical Stage Products 17 comparative Analysis 17 early Clinical Stage Products 18 comparative Analysis 18 discovery And Pre-clinical Stage Products 19 comparative Analysis 19 h1n1 Infection Therapeutics - Products Under Development By Companies 20 h1n1 Infection Therapeutics - Products Under Investigation By Universities/institutes 23 companies Involved In H1n1 Infection Therapeutics Development 24 baxter International Inc. 24 johnson & Johnson 25 sanofi-aventis 26 glaxosmithkline Plc 27 inovio Biomedical Corporation 28 celltrion, Inc. 29 novartis Ag 30 cel-sci Corporation 31 avi Biopharma Inc. 32 opko Health, Inc. 33 medicago Inc. 34 nanoviricides, Inc. 35 novabay Pharmaceuticals, Inc. 36 medigen Biotechnology Corp. 37 xoma Ltd. 38 cytos Biotechnology Ag 39 synairgen Plc 40 bioalliance Pharma Sa 41 antigen Express, Inc. 42 colby Pharmaceutical Company 43 marinomed Biotechnologie Gmbh 44 H1N1 Infection - Pipeline Review, H2 2013
  3. 3. ligocyte Pharmaceuticals, Inc. 45 pt. Bio Farma 46 technovax, Inc. 47 alphavax, Inc. 48 epivax, Inc. 49 kineta, Inc. 50 replicor Inc. 51 protein Sciences Corporation 52 etubics Corporation 53 canopus Biopharma Incorporated 54 ibio, Inc. 55 sirnaomics, Inc. 56 vaxart, Inc. 57 serum Institute Of India Limited 58 immuneregen Biosciences, Inc. 59 cilian Ag 60 revivicor, Inc. 61 vaxine Pty Ltd 62 beijing Minhai Biotechnology Co., Ltd 63 h1n1 Infection - Therapeutics Assessment 64 assessment By Monotherapy Products 64 assessment By Combination Products 65 assessment By Route Of Administration 66 assessment By Molecule Type 68 drug Profiles 70 homspera - Drug Profile 70 flu Vaccine - Drug Profile 72 nv-inf-2 - Drug Profile 73 rep-9-ac - Drug Profile 74 h1n1 Vaccine - Drug Profile 76 vaccine For Pandemic Influenza (h1 & H5) - Drug Profile 78 nvc-612 - Drug Profile 79 panblok - Drug Profile 80 influenza Vaccine - Drug Profile 82 interferon Beta - Drug Profile 83 pandemic Flu Vaccine - Drug Profile 85 gsk-2340273a - Drug Profile 86 stp-702 - Drug Profile 89 f-10 Antibody Program - Drug Profile 90 tvx-002 - Drug Profile 91 radavirsen - Drug Profile 92 (statin + Caffeine) - Drug Profile 93 hac1 Vaccine - Drug Profile 94 H1N1 Infection - Pipeline Review, H2 2013
  4. 4. mf59-eh1n1 Influenza Vaccine - Drug Profile 95 influenza Vlp Vaccine - Drug Profile 96 pandemic H1n1 Vaccine - Drug Profile 97 h1n1 Flu Treatment - Drug Profile 98 influenza Vaccine Qb-flu - Drug Profile 99 iota-carrageenan - Drug Profile 100 tmb-571 - Drug Profile 102 flufirvitide-3 - Drug Profile 103 trimeric Aichi Ha Vaccine - Drug Profile 104 jvrs-100 + Universal Influenza Vaccine - Drug Profile 105 influenza Vaccine - Drug Profile 107 ino-3510 - Drug Profile 108 ino-3401 - Drug Profile 110 aea-35p - Drug Profile 112 ino-3605 - Drug Profile 113 ino-3609 - Drug Profile 115 h1n1 Influenza Vaccine - Drug Profile 117 innate Immune Agonists - Drug Profile 119 h1n1 Syncon Universal Influenza Vaccine - Drug Profile 120 ba-032 - Drug Profile 121 trivalent Live-attenuated Influenza Vaccine - Drug Profile 122 ciflu - Drug Profile 124 human Antibody Based Vaccines - Drug Profile 126 chimigen Influenza Vaccine - Drug Profile 128 universal Flu Vaccine - Drug Profile 129 h1n1 Pandemic Flu Vaccine - Drug Profile 130 matriptase Inhibitors - Drug Profile 131 greflu/cal - Drug Profile 132 pam2cys - Drug Profile 133 pam2cys Vaccine - Drug Profile 134 h1n1 Genetic Vaccine - Drug Profile 135 h1n1 Infection Therapeutics - Drug Profile Updates 136 h1n1 Infection Therapeutics - Dormant Products 149 h1n1 Infection - Product Development Milestones 150 featured News & Press Releases 150 appendix 159 methodology 159 coverage 159 secondary Research 159 primary Research 159 expert Panel Validation 159 contact Us 160 disclaimer 160 H1N1 Infection - Pipeline Review, H2 2013
  5. 5. ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ H1N1 Infection - Pipeline Review, H2 2013

×